Outlook Published: 26 November 2014 Immunology: Oral solutions Elie Dolgin Nature 515, S166–S167 (2014) Cite this article ...

Paclitaxel is a most widely used anticancer drug with low oral bioavailability, thus it is currently administered via intravenous infusion. DHP107 is a lipid-based paclitaxel formulation that can ...

At Kenvue, we learn, test, partner and optimize to bring real solutions into communities, homes and consumers’ hands. Using cutting-edge science and technology, we work diligently to earn people’s ...

Azurity Pharmaceuticals, Inc. announced today the availability of BRYNOVIN™ (sitagliptin) oral solution, a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to ...

Hyderabad: Oral solutions work better than eye drops to treat chronic eye allergies that are reported especially among young men during summer, found a recent study conducted by doctors at the LV ...

References Vertice launches Thyquidity™ (levothyroxine sodium) oral solution. [press release]. New Providence, NJ: Vertice Pharma; February 24, 2021. Thyquidity [package insert].

Key Takeaways Liporaxel oral solution showed non-inferiority in PFS and superiority in OS compared to IV Liporaxel in advanced gastric cancer patients. The phase 3 trial involved 536 patients, with a ...

IMKELDI is an oral solution of imatinib mesylate, a tyrosine kinase inhibitor, approved by the U.S. Food and Drug Administration for use in certain forms of leukemia (such as acute lymphoblastic ...

A voluntary recall has been issued for an oral solution of levothyroxine sodium due to possible subpotency among some of the manufactured products, according to a company press release. IBSA ...

Vimpat is a C-V controlled substance. Vimpat oral solution is available in a 10mg/mL dosage strength. For more information call (800) 477-7877 or visit www.vimpat.com.